ODI Pharma26. Aug. 20214 Min.ODI Pharma AB: Publication of year-end report for the financial year 2020/2021ODI Pharma AB (“ODI” or the “Company”) hereby publishes its year-end report for the fourth quarter and financial year 1st of July 2020 –...
ODI Pharma17. Aug. 20213 Min.ODI Pharma AB approves the official launch of kandol., an exclusive CBD infused skincare lineODI Pharma AB (“ODI Pharma” or the “Company”), a producer and representative of finished pharmaceutical cannabis and cosmetics products,...
ODI Pharma9. Juli 20212 Min.ODI Pharma AB: Flagging notificationODI Pharma AB (“ODI Pharma”) has been informed that Mr. Niclas Kappelin has acquired 20’000 shares in ODI Pharma and exceeded the...
ODI Pharma27. Mai 20214 Min.ODI Pharma AB: Publication of interim report for the third quarter 2020/2021ODI Pharma AB (“ODI” or “the Company”) hereby publishes its interim report concerning the period July 2020 – March 2021. The report is...
ODI Pharma21. Apr. 20213 Min.ODI Pharma: Update on progress in “Project Poland” and “Project Skin” In January 2021 and February 2021, ODI Pharma AB (“ODI” or the “Company”) announced the decision to expand its current business with...